Karuna Therapeutics, Inc. (KRTX)
Company Info
| ISIN | US48576A1007 |
|---|---|
| CUSIP | 48576A100 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $12.60B |
|---|---|
| EPS (TTM) | -$11.74 |
| Gross Profit (TTM) | -$905.00K |
| EBITDA (TTM) | -$265.36M |
| Year Range | $158.38 - $329.99 |
| Target Price | $324.17 |
| Short % | 6.03% |
| Short Ratio | 3.60 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Karuna Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | N/A | 17.79% |
| 1 month | N/A | 0.18% |
| 6 months | N/A | 7.53% |
| 1 year | N/A | 26.42% |
| 5 years (annualized) | N/A | 13.48% |
| 10 years (annualized) | N/A | 10.85% |
Monthly Returns
The table below presents the monthly returns of KRTX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.98% | 0.18% | 4.21% | ||||||||||
| 2023 | 1.47% | 0.02% | -8.92% | 9.25% | 14.17% | -4.28% | -7.88% | -6.01% | -9.94% | -1.47% | 14.77% | 65.53% | 61.07% |
| 2022 | -15.22% | -5.46% | 20.75% | -12.09% | -6.41% | 21.27% | 2.96% | 95.82% | -11.81% | -2.49% | 7.28% | -16.49% | 50.00% |
| 2021 | -2.32% | 25.93% | -3.79% | -7.67% | 0.73% | 1.94% | 0.20% | 4.10% | 2.88% | 14.76% | -8.89% | 2.42% | 28.95% |
| 2020 | 25.98% | -8.06% | -17.49% | 15.39% | 12.98% | 18.75% | -26.61% | -6.60% | 1.20% | 5.01% | 22.88% | 1.82% | 34.84% |
| 2019 | -8.44% | 7.86% | -17.45% | -14.71% | 416.38% | 4.81% | 276.32% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of KRTX is 88, placing it in the top 12% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Karuna Therapeutics, Inc. (KRTX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Karuna Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Karuna Therapeutics, Inc. was 58.17%, occurring on Oct 15, 2019. Recovery took 24 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -58.17% | Jul 8, 2019 | 71 | Oct 15, 2019 | 24 | Nov 18, 2019 | 95 |
| -51.28% | Nov 20, 2019 | 81 | Mar 18, 2020 | 225 | Feb 8, 2021 | 306 |
| -41.96% | Aug 15, 2022 | 286 | Oct 3, 2023 | 57 | Dec 22, 2023 | 343 |
| -41.05% | Nov 5, 2021 | 127 | May 9, 2022 | 62 | Aug 8, 2022 | 189 |
| -25.56% | Jun 14, 2021 | 48 | Aug 19, 2021 | 49 | Oct 28, 2021 | 97 |
Volatility
Volatility Chart
The current Karuna Therapeutics, Inc. volatility is 3.29%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Karuna Therapeutics, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |